Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Incidence and mortality of hip fractures in the United States.

Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB.

JAMA. 2009 Oct 14;302(14):1573-9. doi: 10.1001/jama.2009.1462.

2.

Trends in hospital care for hip fractures.

Gehlbach SH, Avrunin JS, Puleo E.

Osteoporos Int. 2007 May;18(5):585-91. Epub 2006 Dec 5.

PMID:
17146592
3.

Risk of fractures following cataract surgery in Medicare beneficiaries.

Tseng VL, Yu F, Lum F, Coleman AL.

JAMA. 2012 Aug 1;308(5):493-501. doi: 10.1001/jama.2012.9014.

PMID:
22851116
4.

Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women.

Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR.

JAMA. 2009 Feb 4;301(5):513-21. doi: 10.1001/jama.2009.50.

PMID:
19190316
5.

Hip fracture incidence is decreasing in the high incidence area of Oslo, Norway.

Støen RO, Nordsletten L, Meyer HE, Frihagen JF, Falch JA, Lofthus CM.

Osteoporos Int. 2012 Oct;23(10):2527-34. doi: 10.1007/s00198-011-1888-3. Epub 2012 Jan 14.

PMID:
22246602
6.

Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries.

Wang Z, Ward MM, Chan L, Bhattacharyya T.

Osteoporos Int. 2014 Aug;25(8):2109-16. doi: 10.1007/s00198-014-2738-x. Epub 2014 May 21.

7.

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.

8.

Relative mortality in U.S. Medicare beneficiaries with Parkinson disease and hip and pelvic fractures.

Harris-Hayes M, Willis AW, Klein SE, Czuppon S, Crowner B, Racette BA.

J Bone Joint Surg Am. 2014 Feb 19;96(4):e27. doi: 10.2106/JBJS.L.01317.

9.

Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996-2007.

Wang Z, Bhattacharyya T.

J Bone Miner Res. 2011 Mar;26(3):553-60. doi: 10.1002/jbmr.233.

10.

Recent trends in hip fracture rates by race/ethnicity among older US adults.

Wright NC, Saag KG, Curtis JR, Smith WK, Kilgore ML, Morrisey MA, Yun H, Zhang J, Delzell ES.

J Bone Miner Res. 2012 Nov;27(11):2325-32. doi: 10.1002/jbmr.1684.

11.

Declining incidence trends for hip fractures have not been accompanied by improvements in lifetime risk or post-fracture survival--A nationwide study of the Swedish population 60 years and older.

Karampampa K, Ahlbom A, Michaëlsson K, Andersson T, Drefahl S, Modig K.

Bone. 2015 Sep;78:55-61. doi: 10.1016/j.bone.2015.04.032. Epub 2015 Apr 28.

12.

Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival.

Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B.

Age Ageing. 2010 Mar;39(2):203-9. doi: 10.1093/ageing/afp221. Epub 2010 Jan 14.

PMID:
20075035
13.

Ten-year hip fracture incidence rate trends in a large California population, 1997-2006.

Adams AL, Shi J, Takayanagi M, Dell RM, Funahashi TT, Jacobsen SJ.

Osteoporos Int. 2013 Jan;24(1):373-6. doi: 10.1007/s00198-012-1938-5. Epub 2012 Feb 21.

PMID:
22349963
14.

Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States.

Nair SS, Mitani AA, Goldstein BA, Chertow GM, Lowenberg DW, Winkelmayer WC.

Clin J Am Soc Nephrol. 2013 Aug;8(8):1336-42. doi: 10.2215/CJN.10901012. Epub 2013 May 9.

15.

Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend.

Chevalley T, Guilley E, Herrmann FR, Hoffmeyer P, Rapin CH, Rizzoli R.

Bone. 2007 May;40(5):1284-9. Epub 2007 Jan 4.

PMID:
17292683
16.

Ninety-day mortality after intertrochanteric hip fracture: does provider volume matter?

Forte ML, Virnig BA, Swiontkowski MF, Bhandari M, Feldman R, Eberly LE, Kane RL.

J Bone Joint Surg Am. 2010 Apr;92(4):799-806. doi: 10.2106/JBJS.H.01204.

PMID:
20360501
17.

Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study.

Arias LH, Treceño C, García-Ortega P, Rodríguez-Paredes J, Escudero A, Sáinz M, Salado I, Velasco V, Carvajal A.

Eur J Clin Pharmacol. 2013 Mar;69(3):559-64. doi: 10.1007/s00228-012-1337-z. Epub 2012 Jul 21.

PMID:
22821192
18.

Low incidence of anti-osteoporosis treatment after hip fracture.

Rabenda V, Vanoverloop J, Fabri V, Mertens R, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY.

J Bone Joint Surg Am. 2008 Oct;90(10):2142-8. doi: 10.2106/JBJS.G.00864.

19.

Hip fractures in a city in Northern Norway over 15 years: time trends, seasonal variation and mortality : the Harstad Injury Prevention Study.

Emaus N, Olsen LR, Ahmed LA, Balteskard L, Jacobsen BK, Magnus T, Ytterstad B.

Osteoporos Int. 2011 Oct;22(10):2603-10. doi: 10.1007/s00198-010-1485-x. Epub 2011 Jan 20.

20.

Incidence rates of fragility hip fracture in middle-aged and elderly men and women in southern Norway.

Diamantopoulos AP, Rohde G, Johnsrud I, Skoie IM, Johnsen V, Hochberg M, Haugeberg G.

Age Ageing. 2012 Jan;41(1):86-92. doi: 10.1093/ageing/afr114. Epub 2011 Sep 6.

PMID:
21896555

Supplemental Content

Support Center